Arax Advisory Partners’s PLDT PHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9K Sell
506
-44
-8% -$825 ﹤0.01% 4460
2026
Q2
$9.6K Buy
550
+176
+47% +$3.4K ﹤0.01% 4351
2026
Q1
$7.87K Sell
374
-1,336
-78% -$30.2K ﹤0.01% 2576
2025
Q4
$37.2K Buy
1,710
+1,387
+429% +$28.5K ﹤0.01% 1770
2025
Q3
$6.05K Buy
323
+174
+117% +$3.74K ﹤0.01% 2808
2025
Q2
$3.24K Buy
+149
New +$3.36K ﹤0.01% 2397

Other funds holding PHI

Arax Advisory Partners's PHI Position: Q3 2026 in Review

Arax Advisory Partners reduced its PLDT (PHI) stake by 8% in Q3 2026, selling an estimated $825 and leaving 506 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #4460.

Arax Advisory Partners first reported a position in PHI in Q2 2025 and has held it in 6 quarters since. The position peaked at $37.2K in Q4 2025. 66 funds tracked by Wall St. Rank hold PHI as of Q3 2026.

  • Arax Advisory Partners held 506 shares of PLDT worth $9K as of Q3 2026.
  • Arax Advisory Partners sold 44 PLDT shares in Q3 2026, an estimated $825.
  • PLDT made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #4460 holding.
  • Arax Advisory Partners first reported a position in PLDT in Q2 2025 and has held it in 6 quarters since.
  • Arax Advisory Partners's PLDT position peaked at $37.2K in Q4 2025.
  • 66 funds tracked by Wall St. Rank held PLDT as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.